Who
Raj K. Puri
Chief Regulatory Officer
Company insider
Files Form 4 as: Chief Regulatory Officer, Iovance Biotherapeutics.
In numbers
- Trades disclosed
- 60
- Buys
- 1
- Sells
- 0
- Bought
- $9,744
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Dec 2024
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 May 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —9,766 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $39K4,478 at $8.70 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,766 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,766 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —9,766 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $39K4,478 at $8.70 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —5,470 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $21K2,508 at $8.28 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,470 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,470 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —5,470 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $21K2,508 at $8.28 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —9,766 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $16K3,843 at $4.23 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,766 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,766 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —9,766 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $16K3,843 at $4.23 | filing |
News
Financial Analysis: MannKind (NASDAQ:MNKD) & Iovance Biotherapeutics (NASDAQ:IOVA)IOVA · dailypolitical.com · 22 Oct 2026Undercovered Stocks: Hess Midstream, Iovance Biotherapeutics, Netlist, And MoreIOVA · seekingalpha.com · 19 Oct 2026Comparing MannKind (NASDAQ:MNKD) & Iovance Biotherapeutics (NASDAQ:IOVA)IOVA · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Raj K. Puri; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.